Clinical Implications of HCV Resistance: Laying the Foundation for Optimal Treatment Today and in the Future

Review and discuss key principles of HCV resistance with currently approved direct-acting antiviral agents, the latest resistance data on agents in development, and important considerations for potential future anti-HCV regimens.
Stefan Zeuzem, MD
Program Director
Geoffrey M. Dusheiko, MD, FCP(SA), FRCP
Jean-Michel Pawlotsky, MD, PhD
Christoph Sarrazin, MD

Expert Viewpoints

Christoph Sarrazin, MD, reviews highlights on resistance to direct-acting antiviral agents from the 2011 American Association for the Study of Liver Diseases conference.

Stefan Zeuzem, MD
Program Director
Christoph Sarrazin, MD
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: January 4, 2012 Expiration: January 3, 2013

Jean-Michel Pawlotsky, MD, PhD, emphasizes the importance of optimal drug exposure and adherence levels to avoid the development of resistant hepatitis C virus variants, along with strategies to optimize adherence rates.

Stefan Zeuzem, MD
Program Director
Jean-Michel Pawlotsky, MD, PhD
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: February 27, 2012 Expiration: February 26, 2013

In this Expert Viewpoint, Geoffrey M. Dusheiko, MD, FCP(SA), FRCP, reviews the clinical implications of emerging data on drug resistance in patients treated with currently approved HCV protease inhibitors.

Stefan Zeuzem, MD
Program Director
Geoffrey M. Dusheiko, MD, FCP(SA), FRCP
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: June 13, 2012 Expiration: June 12, 2013
Jointly provided by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Educational grant provided by:
Roche

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?